Search

everythinglearnresearchcommunity

for

Search:↓

Geranylgeraniol from nutmeg may effectively treat hair loss, similar to finasteride and better than minoxidil.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

5α-reduced neurosteroids may help regulate glial cell differentiation.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

AH-001 could be a safer and more effective treatment for hair loss.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

GI197111X is best dissolved in Capmul MCM for trials.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

A new treatment for hair loss shows promise with fewer side effects.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The RHC complex with nicotinamide promotes hair growth and health.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.